Orient EuroPharma Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
May 13, 2022 at 07:51 pm EDT
Share
Orient EuroPharma Co., Ltd. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was TWD 1,143.51 million compared to TWD 1,214.93 million a year ago. Net income was TWD 23.53 million compared to TWD 5.76 million a year ago. Basic earnings per share from continuing operations was TWD 0.27 compared to TWD 0.07 a year ago. Diluted earnings per share from continuing operations was TWD 0.27 compared to TWD 0.07 a year ago.
Orient Europharma Co., Ltd. is principally engaged in the manufacture and distribution of nutritious healthcare products and medical cosmetic products, as well as western drugs. The Company operates nutritious healthcare products and medical cosmetic products segment, providing infant milk powders, nutritious products and functional healthcare products, as well as dermatological preparations, medical hair care series, organic skin care series and medical make-up products, among others; western drugs segment, providing products for cardiovascular diseases, cancer, blood diseases, diabetes, central nervous system diseases and asthma, among others.